A Study of ASP8302 in Participants With Underactive Bladder

NCT03702777 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Underactive Bladder

Interventions

DRUG: ASP8302
DRUG: Placebo

Sponsor

Astellas Pharma Europe B.V.